Yang Chen, Han Xiulan, Wang Jie, Yuan Zheng, Wang Tao, Zhao Mingdong, Han Guowei
1 Department of Physical Examination, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
2 Department of Rehabilitation Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
J Int Med Res. 2019 Apr;47(4):1610-1619. doi: 10.1177/0300060518825428. Epub 2019 Feb 14.
To compare medium-term clinical and radiological outcomes of primary unilateral uncemented (UN) or cemented (CE) femoral component total hip arthroplasty (THA) in elderly patients with osteoporosis.
Consecutive patients with osteoporosis who underwent primary unilateral UN or CE THAs at our institution from 2006 to 2013 were retrospectively reviewed. All consecutive procedures were managed by high-volume surgeons, using UN or CE THA approaches. Follow-up assessments occurred at 1, 3, 6, 9, and 12 months postoperatively, and yearly thereafter. Patient-related functional outcomes were assessed using the Harris Hip Score (HHS). Primary and secondary endpoints were early revision (<5 years) and functional outcome.
In total, 496 primary unilateral THAs (CE, n = 184; UN, n = 182) were assessed with a median follow-up period of 75 months (range, 65-86 months). From 3 months after surgery to the final follow-up, HHS was consistently superior in the CE group. Respective prosthetic loosening rates in the UN and CE groups were 26.4% and 16.8% at a minimum of 5 years. There was a significant difference in rate of early revision (7.6% CE vs. 14.8% UN).
Compared with UN THA, CE THA exhibits a superior outcome in elderly patients with primary osteoporosis.
比较老年骨质疏松患者初次单侧非骨水泥型(UN)或骨水泥型(CE)股骨组件全髋关节置换术(THA)的中期临床和影像学结果。
回顾性分析2006年至2013年在本机构接受初次单侧UN或CE THA的连续性骨质疏松患者。所有连续性手术均由经验丰富的外科医生采用UN或CE THA方法进行处理。术后1、3、6、9和12个月进行随访评估,此后每年随访一次。使用Harris髋关节评分(HHS)评估患者相关的功能结果。主要和次要终点分别为早期翻修(<5年)和功能结果。
总共评估了496例初次单侧THA(CE组184例;UN组182例),中位随访期为75个月(范围65 - 86个月)。从术后3个月至最终随访,CE组的HHS始终更高。UN组和CE组至少5年时的假体松动率分别为26.4%和16.8%。早期翻修率有显著差异(CE组7.6% vs. UN组14.8%)。
与UN THA相比,CE THA在老年原发性骨质疏松患者中表现出更好的结果。